Results 111 to 120 of about 47,826 (189)

Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review. [PDF]

Curr Oncol Rep
Iimura Y, Kuroda S.
europepmc   +1 more source

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with capecitabine in HER2-negative advanced breast cancer: a dose-escalation, phase I study. [PDF]

BMC Med
Liu J, Jiang M, Zhang M, Zhou S, Li M, Shi X, Li L, Yang X, Li P, Tian M, Ma F, Xu B, Li Q.   +12 more
europepmc   +1 more source

Prevalence, Clinical Characteristics, and Factors Associated with Capecitabine-Induced Hand-Foot Syndrome in Patients with Cancer: Evidence from Sudan. [PDF]

Drugs Real World Outcomes
Obeid OK, Yousef BA, Hamadalneel YB, Mustafa MA, Mahmoud AA, Elhag EAA.   +5 more
europepmc   +1 more source

Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Chiddarwar T, Blaes A, Kuntz K.
europepmc   +1 more source

Adherence to oral antineoplastic agents, an overview and meta-analysis. [PDF]

Oncologist
Mourath D, Fohlin H.
europepmc   +1 more source

Treatment of HER2-Positive Brain Metastasis from Cervical Cancer Using Multimodal Therapy Including Pyrotinib: A Case Report. [PDF]

Int J Womens Health
Chen Y, Wen T, Wen X, Lai Z.
europepmc   +1 more source

Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal cancer. [PDF]

ESMO Open
van Eekelen R, Punt CJA, Kwakman JJM, Coupé VMH.   +3 more
europepmc   +1 more source

Capecitabine combined with fecal microbiota transplantation prevents colorectal cancer progression through correction of microbial dysbiosis and immune regulation. [PDF]

Sci Rep
Arshad M, Zhang CY, Gao ZK, Sun H, Xu DQ, Fan CY, Zhang BW, Geng JX, Li Y, Kotusov A, Liu SL, Zhang N, Mu XQ.   +12 more
europepmc   +1 more source

Clinical Validation of Digital PCR-Based ctDNA Detection for Risk Stratification in Residual Triple-Negative Breast Cancer: TRICIA Trial Results. [PDF]

Clin Cancer Res
Roseshter T, Klemantovich A, Lafleur J, Lan C, Cavallone L, Bozek K, Guay J, Elebute O, Jenna S, Ouellette R, McNamara S, Boileau JF, Pelmus M, Brackstone M, Pezo R, Ng T, Aguilar-Mahecha A, Basik M.   +17 more
europepmc   +1 more source

Usefulness of pharmacy outpatient clinic follow-up for maintaining relative dose intensity in patients on adjuvant CAPOX chemotherapy for gastric cancer. [PDF]

Mol Clin Oncol
Nakamura M, Yokokawa T, Kawakami K, Kimura Y, Shimizu H, Kobayashi K, Aoyama T, Suzuki W, Hatori M, Suzuki K, Takahari D, Ogura M, Chin K, Wakatsuki T, Yamaguchi K, Yamaguchi M.   +15 more
europepmc   +1 more source